ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. admERY June 17, 2012 Newsroom You Might Also Like ERYTECH announces management change January 8, 2015 ERYTECH submits EMA Marketing Authorization Application for GRASPA to treat acute lymphoblastic leukemia September 14, 2015 ERYTECH to Host Second Quarter 2019 Conference Call and Business Update September 11, 2019
ERYTECH submits EMA Marketing Authorization Application for GRASPA to treat acute lymphoblastic leukemia September 14, 2015
